Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02640235 · ClinicalTrials.gov registry record · NA
Effectiveness and Safety of CELSTAT for Hemostasis in Intraoperative Tissue Bleeding
A NA study, sponsored by Baxter Healthcare Corporation.
- Completed
- Registry status
- NA
- Development phase
- 260
- Enrollment target
NCT02640235 is a NA study that has completed, run by Baxter Healthcare Corporation. The registered enrollment target is 260 participants.
The verdict
NCT02640235, a NA study, has completed, sponsored by Baxter Healthcare Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 260 participants
- Enrollment target
Study Summary
The study is to evaluate the effectiveness and safety of CELSTAT vs active control.
Interventions
- DEVICE CELSTAT
- DEVICE Surgicel Original
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2016-02-24 |
| Est. Completion | 2017-10-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02640235
The ClinicalTrials.gov registry entry for NCT02640235 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baxter Healthcare Corporation, which has 46 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CELSTAT is the first listed.
NCT02640235 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02640235 about?
NCT02640235 is a clinical study titled "Effectiveness and Safety of CELSTAT for Hemostasis in Intraoperative Tissue Bleeding". The study is to evaluate the effectiveness and safety of CELSTAT vs active control.
What is the current status of trial NCT02640235?
This trial is currently completed. It is a NA study. The enrollment target is 260 participants. The study started on 2016-02-24. Estimated completion is 2017-10-18.
What interventions are being tested in trial NCT02640235?
The interventions under investigation include: CELSTAT (DEVICE), Surgicel Original (DEVICE).
Who is sponsoring clinical trial NCT02640235?
This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.